| Inhalable Particles Containing Rapamycin for Induction of Autophagy in Macrophages Infected with Mycobacterium tuberculosis A Gupta, G Pant, K Mitra, J Madan, MK Chourasia, A Misra Molecular pharmaceutics 11 (4), 1201-1207, 2014 | 79 | 2014 |
| Hyperbranched polymer-functionalized magnetic nanoparticle-mediated hyperthermia and niclosamide bimodal therapy of colorectal cancer cells A Ahmad, A Gupta, MM Ansari, A Vyawahare, G Jayamurugan, R Khan ACS Biomaterials Science & Engineering 6 (2), 1102-1111, 2019 | 43 | 2019 |
| Preparation and preclinical evaluation of inhalable particles containing rapamycin and anti-tuberculosis agents for induction of autophagy A Gupta, D Sharma, J Meena, S Pandya, M Sachan, S Kumar, K Singh, ... Pharmaceutical research 33, 1899-1912, 2016 | 43 | 2016 |
| Targeted pulmonary delivery of inducers of host macrophage autophagy as a potential host-directed chemotherapy of tuberculosis A Gupta, A Misra, V Deretic Advanced drug delivery reviews 102, 10-20, 2016 | 43 | 2016 |
| Inhalable Microparticles Containing Nitric Oxide Donors: Saying NO to Intracellular Mycobacterium tuberculosis RK Verma, AK Singh, M Mohan, AK Agrawal, PRP Verma, A Gupta, ... Molecular pharmaceutics 9 (11), 3183-3189, 2012 | 43 | 2012 |
| Inorganic nanoparticles for natural product delivery: A review J Meena, A Gupta, R Ahuja, M Singh, S Bhaskar, AK Panda Environmental Chemistry Letters 18, 2107-2118, 2020 | 42 | 2020 |
| Nanocarrier composed of magnetite core coated with three polymeric shells mediates LCS-1 delivery for synthetic lethal therapy of BLM-defective colorectal cancer cells A Gupta, A Ahmad, H Singh, S Kaur, N KM, MM Ansari, G Jayamurugan, ... Biomacromolecules 19 (3), 803-815, 2018 | 39 | 2018 |
| Recent advances in nano-engineered approaches used for enzyme immobilization with enhanced activity J Meena, A Gupta, R Ahuja, M Singh, AK Panda Journal of Molecular Liquids 338, 116602, 2021 | 35 | 2021 |
| Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosis RK Verma, AK Agrawal, AK Singh, M Mohan, A Gupta, P Gupta, UD Gupta, ... Tuberculosis 93 (4), 412-417, 2013 | 35 | 2013 |
| Opportunities and challenges for host-directed therapies in tuberculosis M Sachan, A Srivastava, R Ranjan, A Gupta, S Pandya, A Misra Current Pharmaceutical Design 22 (17), 2599-2604, 2016 | 33 | 2016 |
| Polymeric hydrogels for controlled drug delivery to treat arthritis A Gupta, J Lee, T Ghosh, VQ Nguyen, A Dey, B Yoon, W Um, JH Park Pharmaceutics 14 (3), 540, 2022 | 25 | 2022 |
| Particulate pulmonary delivery systems containing anti-tuberculosis agents A Gupta, SM Pandya, I Mohammad, AK Agrawal, M Mohan, A Misra Critical Reviews™ in Therapeutic Drug Carrier Systems 30 (4), 2013 | 19 | 2013 |
| Synthetic lethality: from research to precision cancer nanomedicine A Gupta, A Ahmad, AI Dar, R Khan Current Cancer Drug Targets 18 (4), 337-346, 2018 | 18 | 2018 |
| Dextrose modified flexible tasar and muga fibroin films for wound healing applications CM Srivastava, R Purwar, A Gupta, D Sharma Materials Science and Engineering: C 75, 104-114, 2017 | 18 | 2017 |
| Inhalable particles for “pincer therapeutics” targeting nitazoxanide as bactericidal and host-directed agent to macrophages in a mouse model of tuberculosis A Gupta, J Meena, D Sharma, P Gupta, UD Gupta, S Kumar, S Sharma, ... Molecular Pharmaceutics 13 (9), 3247-3255, 2016 | 15 | 2016 |
| Inhalable particles containing isoniazid and rifabutin as adjunct therapy for safe, efficacious and relapse-free cure of experimental animal tuberculosis in one month AK Singh, RK Verma, JK Mukker, AB Yadav, P Muttil, R Sharma, M Mohan, ... Tuberculosis 128, 102081, 2021 | 13 | 2021 |
| Pharmacokinetics, metabolism, and partial biodistribution of “pincer therapeutic” nitazoxanide in mice following pulmonary delivery of inhalable particles A Gupta, SL Tulsankar, RS Bhatta, A Misra Molecular pharmaceutics 14 (4), 1204-1211, 2017 | 13 | 2017 |
| RBD decorated PLA nanoparticle admixture with aluminum hydroxide elicit robust and long lasting immune response against SARS-CoV-2 J Meena, P Singhvi, S Srichandan, J Dandotiya, J Verma, M Singh, ... European Journal of Pharmaceutics and Biopharmaceutics 176, 43-53, 2022 | 7 | 2022 |
| Selective Targeting of Cancer Cells using Personalized Nanomedicine Gupta A, Ahmad A, Dar A Q, Bhatt A, Khan R Toxicology and Forensic Medicine 1 (1), 1-2, 2016 | 6* | 2016 |
| Inorganic particles for delivering natural products J Meena, A Gupta, R Ahuja, AK Panda, S Bhaskar Sustainable Agriculture Reviews 44: Pharmaceutical Technology for Natural …, 2020 | 4 | 2020 |
